Managing directors Hakan Goker (L) and Owen Lozman, M Ventures
December 8, 2021 08:00 AM EST
Financing
Pharma

Mer­ck KGaA's ven­ture arm is ready to make new in­vest­ments, rais­ing more than $675M to get things go­ing

Max Gelman

Senior Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

FDA picks con­tro­ver­sial doc­tor Vinay Prasad as CBER di­rec­tor, in about-face from Marks

Bri­an Arm­strong’s NewLim­it rais­es a $130M Se­ries B, lay­ing out road map for an­ti-ag­ing drugs

Trump, Con­gress look at match­ing some US drug prices to costs abroad

Ex­clu­sive: Degra­da­tion start­up rais­es $39M for piv­ot to PRO­TACs and clin­i­cal en­try

Ver­tex paus­es study of mR­NA ther­a­py for cys­tic fi­bro­sis

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times